ArticleToxicology letters2025
Exposure to the trichloroethylene metabolite S-(1,2-dichlorovinyl)-L-cysteine under hypoxic conditions (%O
Article in Toxicology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Trichloroethylene (TCE) is a volatile organic compound used as an industrial solvent until the recent EPA phaseout. Despite regulatory restrictions, legacy TCE pollution persists in soil and groundwater and poses a risk to human health. This chemical exerts its toxic effects through its metabolites including the glutathione conjugation metabolite S-(1,2-dichlorovinyl)-L-cysteine (DCVC). Although a known nephrotoxicant, limited research has explored its effects on placental development - despite a reported epidemiological association between maternal exposure and elevated risk of restricted fetal growth. The placenta plays a critical role in the first trimester, functioning under hypoxic conditions to support fetal growth. Extravillous trophoblasts (EVTs), essential for placental development, are sensitive to environmental stressors. In this study, effects of human-relevant DCVC concentrations on cytotoxicity, differential gene expression, and invasion capacity were evaluated and compared under normoxic and hypoxic conditions using the placental EVT cell line HTR-8/SVneo. Differential gene expression between normoxic and hypoxic controls was also evaluated to characterize the simulated hypoxic experimental conditions. DCVC exposure induced significant cytotoxicity at concentrations as low as 10 μM under both normoxic and hypoxic conditions. DCVC also caused differential gene expression under both conditions, with a more robust response under normoxia. Similar biological pathways were altered under both conditions, including those involved in oxidative balance, cell migration, and apoptotic signaling. Invasion capacity significantly decreased with 10 and 20 μM DCVC under normoxia but was partially rescued under hypoxia, indicating a possible protective effect. Overall, HTR-8/SVneo cell responses to DCVC were similar under both oxygen conditions, with some evidence of hypoxia offering mild protection. This study builds on previous literature and offers new evaluation of exposure under different simulated oxygen conditions mimicking those experienced during the first trimester of pregnancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.